BRCA2 and triple-negative breast carcinoma: About 20% of patients with triple-negative breast cancer present mutation in the BRCA1 or BRCA2 genes (Wooster and Weber, 2003), which are essential to the repair of double-strand DNA breaks by homologous recombination repair.